Clinical Trial Update: A Clinical Study of 162 in Subjects With Chronic Hepatitis B Virus Infection [Phase 1]

View source ↗

Summary

Phase 1 trial (NCT06159062) of 162 participants with chronic hepatitis B infection sponsored by Yangshengtang Co., Ltd was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Yangshengtang Co., Ltd | Conditions: Chronic Hepatitis B Virus Infection | Phase 1 | Status: TERMINATED